⌘K

Login Start Free

Home/Filings/4/0001209191-23-021290

4//SEC Filing

Hamm John M. 4

Accession 0001209191-23-021290

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 5:53 PM ET

Size

5.3 KB

Accession

0001209191-23-021290

Insider Transaction Report

Form 4

Period: 2023-03-24

CUMBERLAND PHARMACEUTICALS INCCPIX

Chief Financial Officer

Transactions

Award
Options (right to buy)
2023-03-24+2,000→ 7,000 total
Exercise: $1.97From: 2027-03-24Exp: 2033-03-24→ Common Stock (2,000 underlying)

Footnotes (1)

[F1]100% vesting on March 24, 2027.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001870439

Filing Metadata

Form type: 4
Filed: Mar 26, 8:00 PM ET
Accepted: Mar 27, 5:53 PM ET
Size: 5.3 KB

View on SEC.gov